RE: RE Heading North Everyday12 Jun 2024 13:30
Merck and others you mentioned are more established pharma, tend to be the company's who fund the research, buy or merge on collaborative purposes.
I take c4 therapeutics as example, I bought at 1,19 and sold for $11, simply because Merck come on board and blew the roof off. It's now down at $4 region so I'm gauging that as time passes.
I hold Cardiff oncology and femasys, all 52 week low positions, great profit on upturn but it's a waiting game, can be months which ties up investment funds, but sure gives them in abundance once seen out.
I always look at buying on what I consider a low low sp, what has stagnate. Anything awaiting phase 3 results usually bears fruit. You got to fund these AIM ventures some how, not everyone has deep pockets like Castle 🤣🤣